1 resultado para Breast - Cancer - Treatment

em ABACUS. Repositorio de Producción Científica - Universidad Europea


Relevância:

100.00% 100.00%

Publicador:

Resumo:

Tamoxifen (TAM) has been widely used to treat estrogen receptor (ER)-positive breast cancer, and has led to reduction of 50% in the annual recurrence rate and 30% in breast cancer mortality after 5 years of treatment.1 The prodrug TAM is a selective ER modulator that antagonizes ERs in cancer cells. However, compared with its two active metabolites 4-hydroxy-TAM (4-OH-TAM) and endoxifen, it is a relatively weak antiestrogen.